{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:39:50Z","timestamp":1698590390922},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Lab Res"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1007\/s005990050047","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T23:33:36Z","timestamp":1070408016000},"page":"211-214","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of von Willebrand disease"],"prefix":"10.1007","volume":"28","author":[{"given":"P. M.","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"284211_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","volume":"30","author":"PM Mannucci","year":"1975","unstructured":"Mannucci PM, Aberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30: 81.","journal-title":"Br J Haematol"},{"key":"284211_CR2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","volume":"90","author":"PM Mannucci","year":"1997","unstructured":"Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years. Blood 1997; 90: 2515.","journal-title":"Blood"},{"key":"284211_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","volume":"82","author":"PM Mannucci","year":"1992","unstructured":"Mannucci PM, Bettega D, Cattaneo M. Consistency of responses to repeated DDAVP infusions in patients with von Willebrand disease and haemophilia A. Br J. Haematol 1992; 82: 87.","journal-title":"Br J. Haematol"},{"key":"284211_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830310310","volume":"31","author":"TJ Smith","year":"1989","unstructured":"Smith TJ, Gill JC, Ambroso DR, Hathaway WE. Hyponatremia and seizures in young children given DDAVP. Am J Hematol 1989; 31: 199.","journal-title":"Am J Hematol"},{"key":"284211_CR5","first-page":"121","volume":"318","author":"L Bond","year":"1988","unstructured":"Bond L, Bevin D. Myocardial infarction in a patient with hemophilia A treated with DDAVP. N Engl J Med 1988; 318: 121.","journal-title":"N Engl J Med"},{"key":"284211_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830280115","volume":"28","author":"JJ Byrnes","year":"1988","unstructured":"Byrnes JJ, Larcada A, Moake JL. Thrombosis following desmopressin for uremic bleeding. Am J Hematol 1988; 28: 63.","journal-title":"Am J Hematol"},{"key":"284211_CR7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","volume":"66","author":"PM Mannucci","year":"1985","unstructured":"Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi MG, Mariani G. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 1985; 66: 796.","journal-title":"Blood"},{"key":"284211_CR8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","volume":"309","author":"L Holmberg","year":"1983","unstructured":"Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-d-arginine vasopressin (DDAVP) in type II B von Willebrand disease. N Engl J Med 1983; 309: 816.","journal-title":"N Engl J Med"},{"key":"284211_CR9","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V74.5.1859.1859","volume":"74","author":"WE Fowler","year":"1989","unstructured":"Fowler WE, Berkowitz LR, Roberts HR. DDAVP for type IIB von Willebrand disease. Blood 1989; 74: 1859.","journal-title":"Blood"},{"key":"284211_CR10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","volume":"88","author":"C Mazurier","year":"1994","unstructured":"Mazurier C, Gaucher C, Jorieux S, Goudemand M, the Collaborative Group. Biological effect of desmopressin in eight patients with type 2N (\u2018Normandy\u2019) von Willebrand disease. Br J Haematol 1994; 88: 849.","journal-title":"Br J Haematol"},{"key":"284211_CR11","first-page":"849","volume":"89","author":"G Castaman","year":"1994","unstructured":"Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Factor VIII: C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease. Br J Haematol 1994; 89: 849.","journal-title":"Br J Haematol"},{"key":"284211_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","volume":"339","author":"PM Mannucci","year":"1998","unstructured":"Mannucci PM. Hemostatic drugs. N Engl J Med 1998; 339: 245.","journal-title":"N Engl J Med"},{"key":"284211_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V30.3.375.375","volume":"30","author":"HA Perkins","year":"1967","unstructured":"Perkins HA. Correction of the hemostatic defects in von Willebrand disease. Blood 1967; 30: 375.","journal-title":"Blood"},{"key":"284211_CR14","first-page":"193","volume":"62","author":"F Rodeghiero","year":"1992","unstructured":"Rodeghiero F, Castaman G, Meyer D, Mannucci PM. Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease. Vox Sang 1992; 62: 193.","journal-title":"Vox Sang"},{"key":"284211_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1963.tb05457.x","volume":"9","author":"P Cornu","year":"1963","unstructured":"Cornu P, Larrieu MJ, Caen J, Bernard J. Transfusion studies in von Willebrand disease: effect on bleeding time and factor VIII. Br J Haematol 1963; 9: 189.","journal-title":"Br J Haematol"},{"key":"284211_CR16","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1182\/blood.V79.12.3130.bloodjournal79123130","volume":"79","author":"PM Mannucci","year":"1992","unstructured":"Mannucci PM, Tenconi PM, Castaman F, Rodeghiero F. Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood 1992; 79: 3130.","journal-title":"Blood"},{"key":"284211_CR17","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V83.10.3018.3018","volume":"83","author":"PM Mannucci","year":"1994","unstructured":"Mannucci PM, Lattuada A, Ruggeri ZM. Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood 1994; 83: 3018.","journal-title":"Blood"},{"key":"284211_CR18","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V74.6.1972.1972","volume":"74","author":"M Cattaneo","year":"1989","unstructured":"Cattaneo M, Moia M, Della Valle P, Castellana P, Mannucci PM. DDAVP shortens the prolonged bleeding time of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor. Blood 1989; 74: 1972.","journal-title":"Blood"},{"key":"284211_CR19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V77.9.1901.1901","volume":"77","author":"R Castillo","year":"1991","unstructured":"Castillo R, Monteagudo J, Escolar G, Ordinas A, Magallon M, Martin Villar J. Hemostatic effect of normal platelet transfusion in von Willebrand disease. Blood 1991; 77: 1901.","journal-title":"Blood"},{"key":"284211_CR20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1537-2995.1997.37897424399.x","volume":"37","author":"R Castillo","year":"1997","unstructured":"Castillo R, Escolar G, Monteagudo J, Aznar-Salatti J, Reverter JC, Ordinas A. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect. Transfusion 1997; 37: 785.","journal-title":"Transfusion"},{"key":"284211_CR21","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.92.7.2428","volume":"92","author":"PM Mannucci","year":"1995","unstructured":"Mannucci PM. Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proc Natl Acad Sci U S A 1995; 92: 2428.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"284211_CR22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2141.1992.tb08903.x","volume":"80","author":"J Goudemand","year":"1992","unstructured":"Goudemand J, Mazurier C, Marey A, Caron C, Coupez B, Mizon P, Goudemand M. Clinical and biological evaluation in von Willebrand\u2019s disease of a von Willebrand factor concentrate with low factor VIII activity. Br J Haematol 1992; 80: 214.","journal-title":"Br J Haematol"},{"key":"284211_CR23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","volume":"94","author":"D Menache","year":"1996","unstructured":"Menache D, Aronson DL, Darr F, Montgomery R and the Cooperative Study Group. Pharmacokinetics of von Willebrand factor and factor VIII in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIII synthesis. Br J Haematol 1996; 94: 740.","journal-title":"Br J Haematol"},{"key":"284211_CR24","first-page":"282","volume":"68","author":"M Conti","year":"1986","unstructured":"Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68: 282.","journal-title":"Obstet Gynecol"},{"key":"284211_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.1990.tb02621.x","volume":"75","author":"FI Pareti","year":"1990","unstructured":"Pareti FI, Federici AB, Cattaneo M, Mannucci PM. Spontaneous platelet aggregation during pregnancy in a patient with VWD type II B can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb\/IIIa. Br J Haematol 1990; 75: 86.","journal-title":"Br J Haematol"},{"key":"284211_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V57.1.25.25","volume":"57","author":"PM Mannucci","year":"1981","unstructured":"Mannucci PM, Ruggeri ZM, Ciavarella N, Kazatchkine MD, Mowbray JF. Precipitating antibodies to FVIII\/von Willebrand factor in von Willebrand disease: effects on replacement therapy. Blood 1981; 57: 25.","journal-title":"Blood"},{"key":"284211_CR27","first-page":"348","volume":"125","author":"L Bergamaschini","year":"1995","unstructured":"Bergamaschini L, Mannucci PM, Federici AB, Coppola R, Guzzoni S, Agostoni A. Posttransfusion anaphylactic reaction in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor. J Lab Clin Med 1995; 125: 348.","journal-title":"J Lab Clin Med"},{"key":"284211_CR28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0609.1987.tb01458.x","volume":"39","author":"PM Mannucci","year":"1987","unstructured":"Mannucci PM, Tamaro G, Narchi G, Candotti G, Federici AB, Altieri D, Tedesco F. Life-threatening reaction to FVIII concentrate in a patient with severe VWD and alloantibodies to von Willebrand factor. Eur J Haematol 1987; 39: 467.","journal-title":"Eur J Haematol"},{"key":"284211_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1963.tb05458.x","volume":"9","author":"R Biggs","year":"1963","unstructured":"Biggs R, Matthews JM. The treatment of hemorrhage in von Willebrand\u2019s disease and the blood levels of factor VIII (AHG). Br J Haematol 1963; 9: 203.","journal-title":"Br J Haematol"},{"key":"284211_CR30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0002-9343(68)90070-3","volume":"45","author":"MJ Larrieu","year":"1968","unstructured":"Larrieu MJ, Caen JP, Vainer MH, Sultan Y, Bernard J. Congenital bleeding disorders with long bleeding time and normal platelet count. Am J Med 1968; 45: 354.","journal-title":"Am J Med"},{"key":"284211_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(76)90751-8","volume":"60","author":"D Green","year":"1976","unstructured":"Green D, Potter EV. Failure of AHF concentrate to control bleeding in von Willebrand\u2019s disease. Am J Med 1976; 60: 357.","journal-title":"Am J Med"},{"key":"284211_CR32","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1001\/jama.1976.03270250038023","volume":"236","author":"PM Blatt","year":"1976","unstructured":"Blatt PM, Brinkhous KM, Culp HR, Krauss SJ, Roberts HR. Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities. JAMA 1976; 236: 2770.","journal-title":"JAMA"},{"key":"284211_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-0038-1657591","volume":"78","author":"HP Schwarz","year":"1997","unstructured":"Schwarz HP, Turecek PL, Pichler L, Mitterer A, Mundt W, Dorner F, Roussi J, Drouet L. Recombinant von Willebrand factor. Thromb Haemost 1997; 78: 571.","journal-title":"Thromb Haemost"}],"container-title":["International Journal of Clinical & Laboratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990050047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s005990050047\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990050047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T14:44:59Z","timestamp":1585320299000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s005990050047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["284211"],"URL":"https:\/\/doi.org\/10.1007\/s005990050047","relation":{},"ISSN":["0940-5437","1434-4467"],"issn-type":[{"value":"0940-5437","type":"print"},{"value":"1434-4467","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}